Catheter Precision shares surge 13.93% intraday after securing first Germany LockeT purchase order from Frankfurt University Hospital.

Catheter Precision surged 13.93% intraday after announcing its first LockeT purchase order in Germany from Universitätsklinikum Frankfurt, a leading university hospital. The order marks the device’s official market entry and positions the company to scale in Europe’s largest healthcare market, valued at $900 million in 2024. The hospital’s adoption of LockeT, a cost-effective suture retention device, validates its clinical value and serves as a strategic reference site for broader European expansion. CEO David Jenkins emphasized the milestone as a “definitive turning point,” underscoring Germany’s role as a hub for medical innovation and high-tech adoption. The news directly aligns with the stock’s sharp rise, reflecting investor optimism over commercialization progress and market potential.